ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,809, issued on Feb. 18.
"Robust genomic predictor of breast and lung cancer metastasis" was invented by Harry Ostrer (New York), Johnny C. Loke (Valley Cottage, N.Y.) and Alexander Pearlman (New York).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of determining the risk of metastasis of breast or lung cancer in a human subject who has or had breast or lung cancer is disclosed herein. The method is based on detecting in a sample from the subject the number of copies per cell of genes and/or genomic regions of a metastatic gene signature set disclosed herein, and determining alternations in the number of copies per cell of the genes and/or ge...